Keating Financial Advisory Services’s GeneDx Holdings WGS Stock Holding History

Keating Financial Advisory Services’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$892	Hold	13	–	–	﹤0.01%	2202
2026 Q1	$835	Buy	13 +11	+550%	+$1K	﹤0.01%	2133
2025 Q4	$260	Buy	+2	New	+$275	﹤0.01%	2040

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Keating Financial Advisory Services's WGS Position: Q2 2026 in Review

Keating Financial Advisory Services held its GeneDx Holdings (WGS) position steady in Q2 2026 at 13 shares worth $892. The position accounts for ﹤0.01% of the portfolio, ranked #2202.

Keating Financial Advisory Services first reported a position in WGS in Q4 2025 and has held it in 3 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Keating Financial Advisory Services held 13 shares of GeneDx Holdings worth $892 as of Q2 2026.
Keating Financial Advisory Services left its GeneDx Holdings share count unchanged in Q2 2026.
GeneDx Holdings made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #2202 holding.
Keating Financial Advisory Services first reported a position in GeneDx Holdings in Q4 2025 and has held it in 3 quarters since.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.